M-9, r. 12.2 - Regulation respecting certain professional activities that may be engaged in by a pharmacist

Section 6 Disposition versions

2015-06-20

6. A pharmacist who engages in professional activities in a community pharmacy may prescribe the laboratory analyses provided for in Schedule II for the purpose of supervising medication therapy

(1)  to substantiate the presence of known adverse effects associated with the taking of medication;

(2)  to ensure follow-up on known adverse effects and drug interactions;

(3)  to ensure follow-up on the effectiveness of medication therapy.

Before requesting an analysis, the pharmacist must ensure that no recent result of the analysis for the patient is otherwise available.

The pharmacist communicates to the attending physician or the specialized nurse practitioner responsible for the clinical follow-up the result of the requested laboratory analysis. The pharmacist must, where appropriate, refer the patient to the resource appropriate to the patient’s condition, with the results of the analysis.

O.C. 606-2013, s. 6.